| Company: | Danaher Corporation |
|---|---|
| CEO: |
|
| Founded: | 1969 |
| Symbol: | DHR |
| Exchange: | NYSE |
| Industry: | Medical - Diagnostics & Research |
| Sector: | Healthcare |
| About |
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia. |
15 among 2804 companies
2200 Pennsylvania Avenue, NW
Washington | DC |
US
| Danaher Corporation;DHR;http://bullfincher.io/logos/us/DHR.png;danaher-corporation | 24568000000.00 |
|---|---|
| Agilent Technologies;A;https://financialmodelingprep.com/image-stock/A.png;agilent-technologies | 6948000000.00 |
| Thermo Fisher Scientific;TMO;http://bullfincher.io/logos/us/TMO.png;thermo-fisher-scientific | 44556000000.00 |
Danaher Corporation was founded on 1969, which makes the company 57 years old.
Rainer Blair is the CEO of Danaher Corporation.
Danaher Corporation operates in the Medical - Diagnostics & Research industry and the Healthcare sector.
Danaher Corporation has 60,000 employees.
In fiscal year 2025, Danaher Corporation generated a revenue of $24.57 Billion.
In fiscal year 2025, Danaher Corporation reported a net income of $3.61 Billion.
Revenue from Contract with Customer, Measurement, Recurring is Danaher Corporation's biggest product segment, representing 81.92% of its total revenue.
Danaher Corporation went public on Dec 29, 1978, through its Initial Public Offering (IPO), and it has been 47 years since then.
Danaher Corporation's ticker symbol is DHR, and the company is listed on the NYSE stock market exchange.
Danaher Corporation's current stock price is $182.68 as of May 30, 2026.
Ranked #15among 2,804 companies based on market cap.
Competitors of Danaher Corporation include Agilent Technologies and Thermo Fisher Scientific, and more.